Orthofix Int'l (OFIX) Prelim. FY15 Revenue Edges-Out Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Orthofix Announces Preliminary Fourth Quarter 2015 and Full Year Net Sales Results
January 12, 2016 4:00 PM ESTLEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix International N.V. (NASDAQ: OFIX), a diversified, global medical device company, today announced preliminary unaudited fourth quarter 2015 net sales of approximately $105 million. These preliminary results represent a reported sales growth of 4.3% and constant currency sales growth of 7.6% over the fourth quarter 2014. For the full year 2015, preliminary unaudited net sales were approximately $396 million, which decreased 1.4% on a reported basis and increased 2.4% on a constant currency basis over the full year 2014.
  Three Months Ended December 31, (Unaudited, U.S. Dollars, in millions)2015
  2014  ÂReportedGrowth
 ÂConstantCurrencyGrowth
BioStim$
45
$ 40 Â13
% Â13
% Biologics... More